Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Graham

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
Circulation. Cardiovascular Quality and Outcomes|October 5, 2020
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial FibrillationXiaoxi Yao, Jonathan W Inselman, Joseph S Ross, et al.
The American Journal of Medicine|July 16, 2023
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare BeneficiariesDavid J Graham, Hector S Izurieta, Di Zhang, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomaliesCraig Hansen, Susan E Andrade, Heather Freiman, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
Circulation. Cardiovascular Quality and Outcomes|October 5, 2020
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial FibrillationXiaoxi Yao, Jonathan W Inselman, Joseph S Ross, et al.
The American Journal of Medicine|July 16, 2023
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare BeneficiariesDavid J Graham, Hector S Izurieta, Di Zhang, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
Pharmacoepidemiology and Drug Safety|November 25, 2015
Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomaliesCraig Hansen, Susan E Andrade, Heather Freiman, et al.
Pharmacoepidemiology and Drug Safety|January 11, 2018
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel SystemElizabeth A Chrischilles, Joshua J Gagne, Bruce Fireman, et al.
Pageof 17